Not all patients with CLL call for therapy. Irrespective of all current improvements, the iwCLL even now suggests watchful observation for individuals with asymptomatic condition.86 This advice is based on at the least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Each trials https://petere715vfo0.azzablog.com/profile